CN Patent

CN111094272B — 一种otr抑制剂的可药用盐、晶型及制备方法

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2022-05-27 · 4y expired

What this patent protects

提供了一种OTR抑制剂的可药用盐、晶型及制备方法。具体而言，提供了一种OTR抑制剂5‑(3‑(3‑(6‑氟萘‑1‑基)氮杂环丁烷‑1‑基)‑5‑(甲氧基甲基)‑4H‑1,2,4‑三氮唑‑4‑基)‑2‑甲氧基吡啶可药用盐、晶型及制备方法。该可药用盐改善了OTR抑制剂的游离碱溶出度，物理或化学稳定性，对开发适合工业生产且生物活性良好的药物是具有重要意义。

USPTO Abstract

提供了一种OTR抑制剂的可药用盐、晶型及制备方法。具体而言，提供了一种OTR抑制剂5‑(3‑(3‑(6‑氟萘‑1‑基)氮杂环丁烷‑1‑基)‑5‑(甲氧基甲基)‑4H‑1,2,4‑三氮唑‑4‑基)‑2‑甲氧基吡啶可药用盐、晶型及制备方法。该可药用盐改善了OTR抑制剂的游离碱溶出度，物理或化学稳定性，对开发适合工业生产且生物活性良好的药物是具有重要意义。

Drugs covered by this patent

Patent Metadata

Patent number
CN111094272B
Jurisdiction
CN
Classification
—
Expires
2022-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.